Cryptogenic small-fiber neuropathies: Serum autoantibody binding to trisulfated heparan disaccharide and fibroblast growth factor receptor-3.

MLA

Levine, Todd D., et al. “Cryptogenic Small-Fiber Neuropathies: Serum Autoantibody Binding to Trisulfated Heparan Disaccharide and Fibroblast Growth Factor Receptor-3.” Muscle & Nerve, vol. 61, no. 4, Apr. 2020, pp. 512–15. EBSCOhost, https://doi.org/10.1002/mus.26748.

APA

Levine, T. D., Kafaie, J., Zeidman, L. A., Saperstein, D. S., Massaquoi, R., Bland, R. J., & Pestronk, A. (2020). Cryptogenic small-fiber neuropathies: Serum autoantibody binding to trisulfated heparan disaccharide and fibroblast growth factor receptor-3. Muscle & Nerve, 61(4), 512–515. https://doi.org/10.1002/mus.26748

Chicago

Levine, Todd D., Jafar Kafaie, Lawrence A. Zeidman, David S. Saperstein, Reyanna Massaquoi, Ruth J. Bland, and Alan Pestronk. 2020. “Cryptogenic Small-Fiber Neuropathies: Serum Autoantibody Binding to Trisulfated Heparan Disaccharide and Fibroblast Growth Factor Receptor-3.” Muscle & Nerve 61 (4): 512–15. doi:10.1002/mus.26748.